Axogen Inc (NASDAQ:AXGN) price on Friday, April 11, rose 0.57% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $15.89.
A look at the stock’s price movement, the close in the last trading session was $15.80, moving within a range at $15.17 and $16.22. The beta value (5-Year monthly) was 0.994. Turning to its 52-week performance, $21.00 and $5.55 were the 52-week high and 52-week low respectively. Overall, AXGN moved -7.40% over the past month.
Axogen Inc’s market cap currently stands at around $704.62 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-24.
Analysts have a consensus estimate of 48.35M for the company’s revenue for the quarter, with a low and high estimate of 47.2M and 49M respectively. The average forecast suggests up to a 16.84% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 216.78M, representing a 15.71% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that AXGN is a Hold. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend AXGN as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
AXGN’s current price about -9.48% and -11.53% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 38.27, while 7-day volatility ratio is 9.79% and 6.13% in the 30-day chart. Further, Axogen Inc (AXGN) has a beta value of 1.22, and an average true range (ATR) of 1.15.
If we refocus on Axogen Inc (NASDAQ:AXGN), historical trading data shows that trading volumes averaged 0.55 over the past 10 days and 531.67K over the past 3 months. The company’s latest data on shares outstanding shows there are 44.15 million shares.
The 5.67% of Axogen Inc’s shares are in the hands of company insiders while institutional holders own 81.62% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 1.51 million on 2025-03-14, giving us a short ratio of 2.37. The data shows that as of 2025-03-14 short interest in Axogen Inc (AXGN) stood at 404.0 of shares outstanding, with shares short falling to 1.85 million registered in 2025-02-14. Current price change has pushed the stock -3.58% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the AXGN stock continues to rise going into the next quarter.
